, , , , , e.a.

Nanotherapeutics in Cancer Vaccination and Challenges

Specificaties
Paperback, blz. | Engels
Elsevier Science | e druk, 2022
ISBN13: 9780128236864
Rubricering
Juridisch :
Elsevier Science e druk, 2022 9780128236864
€ 241,00
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects.

Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy.

Specificaties

ISBN13:9780128236864
Taal:Engels
Bindwijze:Paperback

Inhoudsopgave

1. Cancer vaccines: Past, present and future<br>2. Inorganic Nanoparticulate Carriers in management of Cancer: Theranostic and Toxicity Apprehension<br>3. Recent developments in cancer vaccines: Where are we?<br>4. Application of Nanotechnology assisted devices in cancer treatment<br>5. Protein Based Nanocarriers as a Potent Drug Delivery Vehicle for Cancer Therapy<br>6. Nanoparticle-based manipulation of antigen-presenting cells for cancer immunotherapy<br>7. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies<br>8. Peptide based anticancer targeted therapeutics: State of the Art<br>9. Polyplexes-based delivery systems for cancer vaccine delivery<br>10. Lipopolyplexes-based delivery system for cancer vaccine delivery<br>11. Inorganic nanoparticulate carriers in cancer vaccination<br>12. Functional nanomaterials and nanocomposites in cancer vaccines<br>13. DNA vaccines for cancer treatment: Challenges and promises<br>14. mRNA-based nanovaccines as newer treatment modalities in cancer<br>15. Cancer immunotherapy: Moving forward with peptide T cell vaccines<br>16. Product development and scale-up challenges in cancer vaccine development<br>17. Regulatory landscape in the approval of cancer vaccines<br>18. Cross-Presentation-based Nanovaccine for Cancer Immunotherapy<br>19. Immunotherapy based cancer Vaccines: State of the art<br>20. Therapeutics peptides in Anticancer therapy<br>21. Inorganic Nanoconjugates For Cancer Theragnosis

Net verschenen

€ 241,00
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Nanotherapeutics in Cancer Vaccination and Challenges